Bavencio

Bavencio (Avelumab) is an intravenous medication used for cancer treatment. This immunotherapy targets specific proteins to help the immune system fight cancer cells.

Bavencio is primarily used in the treatment of certain types of cancer. It works by targeting a protein called PD-L1, which can help the immune system recognize and attack cancer cells. This medication is often used in combination with other treatments to enhance its effectiveness.

Common effects of Bavencio may include fatigue, nausea, and infusion-related reactions. Some patients may also experience skin reactions or changes in blood pressure. These effects can vary from person to person.

Bavencio should be administered under the supervision of a healthcare professional. It is important to discuss any existing medical conditions or allergies before starting treatment. Regular monitoring may be required to manage potential side effects.

Bavencio may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Bavencio.